Mary Grace N. Tamio

Mary Grace N. Tamio

在 January 06 2022 at 03:40 PM 已編輯

Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma

#relatimab #nivolumab #melanoma

For more information | ⬇️
https://cn1699.com/news/relatlimab-plus-nivolumab-improves-progression-free-survival-metastatic-melanoma

Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma | CN1699
In patients with untreated, advanced melanoma, the combination of immune checkpoint inhibitors relatlimab and nivolumab doubled the...
0 0 0 0 0 0 0

留言

Like

分享
- 請登入或註冊